Accord Healthcare, Inc. 2023-01-25 Health critical FDA
Health · FDA · Recall #FDA-D-0131-2023
Daptomycin for Injection 350 mg/vial 1 Single-dose vial, Rx only, Manufactured for:… Recall
Issued January 25, 2023 · Accord Healthcare, Inc.
In January 2023, Accord Healthcare, Inc. recalled the Daptomycin for Injection 350 mg/vial 1 Single-dose vial, Rx only, Manufactured for:…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial
What you should do
- 1 Stop using Daptomycin for Injection 350 mg/vial 1 Single-dose vial, Rx only, Manufactured for:… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Accord Healthcare, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Accord Healthcare, Inc.
- Category
- Health
- Recall date
- January 25, 2023
- Units affected
- Not reported
- Sold at
- Nationwide within the United States
- Recall number
- FDA-D-0131-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Accord Healthcare, Inc. has 31 recalls in our database, including 1 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.